Stereotactic Body Radiation Therapy With Continued First-Line PD-1 Inhibitor-based Therapy as a Resistance-Overcoming Strategy in Oligoprogressive Hepatocellular Carcinoma: A Prospective Phase 2 Clinical Study

International Journal of Radiation Oncology*Biology*Physics 2026

View at publisher
Authors: Shu-Jung Hsu, Yen-cheng Chao, Siwei Wang, Qiu-Yi Zheng, Yong Hu, Yang Zhang, Xiao-bin Zheng, Peng-jun Xie, Zhi-Gang Fu, Yi-xing Chen, Zhao-chong Zeng, Rong-xin Chen
+1 more Shi-Suo Du
DOI: 10.1016/j.ijrobp.2025.12.049
Cited by: 0
References: 33

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Cancer Immunotherapy and Biomarkers Cholangiocarcinoma and Gallbladder Cancer Studies

Publication details

Journal / source
International Journal of Radiation Oncology*Biology*Physics
Volume
124
Issue
5
Pages
1388–1398
Publication date
10 January 2026
Language
EN